Domain Ex
Content
A Hidden Pharma Pharma and Biotech Job Market February 2014
Highly-experienced management CEO • Dr Eddy Littler - CEO
– 10 years in academia in Canada and UK – Senior scientific and management roles at Wellcome Research Laboratories, GlaxoWellcome, Medivir – Industry advisor to The Astbury Centre, University University of
Leeds, Wellcome Wellcome Trust, CN Bio
•
Dr Trevor Trevor Perrior FRSC - Research Direc Director tor – Senior research leader and manager with ICI, AstraZeneca, AstraZeneca, Celltech – Visiting Professor of Medicinal Chemistry at University of Sussex, Chair of the Translatio Translational nal Drug Discovery Steering Group – Consultant to medical charities & venture capital funds
Highly-experienced management
• Prof Professor essor Laurence Pearl FRS - CSO and a nd Founder – Professor Professor of Structural Biology and Head of Life Sciences, University of Sussex – Director of the MRC Genome Stability Centre
•
Dr Joanne McCudden – Head of Business Development – Over 10 years in biotech business development – SynCo Bio Partners (NL) – Genaissance (US) – Cobra Bio (UK)) – PhD in biological sciences from Warwick
Domainex – Hybrid Biotech Company • A pharmaceutical research company – Established in 2001 based at Cambridge, UK – Currently around 30 staff
• Provide drug discovery discovery services ser vices and consultancy - from target to candidate drug – – – – – –
Protein expression Structural biology Biochemistry Hit finding Medicinal and computational chemistry Physicochemical profiling and DMPK
• Revenue generation enables support of internal pipeline
Excellence in drug discovery • Over the last 6 years:
– Three Client projects to the clinic clinic – Three Client compounds currently in pre-clinical development development
• Cited as inventors inventors on on more than 70 patents Authors on on over 130 peer-reviewed papers • Authors • We support global organisation organisationss in all sectors: large pharma, biotech, academic, and start-ups
Highly-experienced management CEO • Dr Eddy Littler - CEO
– 10 years in academia in Canada and UK – Senior scientific and management roles at Wellcome Research Laboratories, GlaxoWellcome, Medivir – Industry advisor to The Astbury Centre, University University of
Leeds, Wellcome Wellcome Trust, CN Bio
•
Dr Trevor Trevor Perrior FRSC - Research Direc Director tor – Senior research leader and manager with ICI, AstraZeneca, AstraZeneca, Celltech – Visiting Professor of Medicinal Chemistry at University of Sussex, Chair of the Translatio Translational nal Drug Discovery Steering Group – Consultant to medical charities & venture capital funds
Highly-experienced management
• Prof Professor essor Laurence Pearl FRS - CSO and a nd Founder – Professor Professor of Structural Biology and Head of Life Sciences, University of Sussex – Director of the MRC Genome Stability Centre
•
Dr Joanne McCudden – Head of Business Development – Over 10 years in biotech business development – SynCo Bio Partners (NL) – Genaissance (US) – Cobra Bio (UK)) – PhD in biological sciences from Warwick
Domainex – Hybrid Biotech Company • A pharmaceutical research company – Established in 2001 based at Cambridge, UK – Currently around 30 staff
• Provide drug discovery discovery services ser vices and consultancy - from target to candidate drug – – – – – –
Protein expression Structural biology Biochemistry Hit finding Medicinal and computational chemistry Physicochemical profiling and DMPK
• Revenue generation enables support of internal pipeline
Excellence in drug discovery • Over the last 6 years:
– Three Client projects to the clinic clinic – Three Client compounds currently in pre-clinical development development
• Cited as inventors inventors on on more than 70 patents Authors on on over 130 peer-reviewed papers • Authors • We support global organisation organisationss in all sectors: large pharma, biotech, academic, and start-ups
